Chris O'Meara, Associated Press
NEW BRUNSWICK, N.J. — Johnson & Johnson says its first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales. The world's biggest maker of health care products easily beat Wall Street expectations and raised its earnings outlook.
The maker of Tylenol, medical devices and prescription drugs said Tuesday that net income was $4.73 billion, or $1.64 per share, up from $3.5 billion, or $1.22 per share, a year earlier.
Excluding one-time items, income was $4.43 billion, or $1.54 per share. Analysts surveyed by FactSet expected $1.48.
Revenue totaled $18.12 billion, up 3.5 percent. Analysts expected $18.04 billion.
The company, based in New Brunswick, N.J., raised its profit forecast for 2014 to $5.80 to $5.90 per share. In January, J&J forecast $5.75 to $5.85.
- AP PHOTOS: A selection of pictures from the...
- Scientists work toward storing digital...
- 7 tips for summer travel while pregnant
- How to vanquish the dreaded 'Dad Bod'
- Chevron wants to stop monitoring Red Butte...
- Amid algal bloom scare, Riverton residents...
- Looking for a new job? Here is a way to...
- Seeking social media 'likes' could cause...
- Planned Parenthood 'CTR' campaign draws... 23
- Looking for a new job? Here is a way to... 2
- Seeking social media 'likes' could... 2
- Scientists work toward storing digital... 1
- How to vanquish the dreaded 'Dad Bod' 1
- Chevron wants to stop monitoring Red... 1
- Amid algal bloom scare, Riverton... 1
- AP PHOTOS: A selection of pictures from... 0